Anti-ALK antibody [SP8], prediluted (ab27599)


  • Product nameAnti-ALK antibody [SP8], prediluted
    See all ALK primary antibodies
  • Description
    Rabbit monoclonal [SP8] to ALK, prediluted
  • Specificityab27599 recognises human p80 protein.
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant protein corresponding to a region, which spans the tyrosine kinase catalytic domain and part of the C-terminus of the NPM-ALK transcript.

  • Positive control
    • Anaplastic lymphoma



Our Abpromise guarantee covers the use of ab27599 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesIHC-P: Ready to use for 10 minutes at room temperature. Staining of formalin-fixed tissues is required by boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 minutes followed by cooling at room temperature for 20 minutes.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionNeuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system. Transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction. Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase. Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK.
    • Tissue specificityExpressed in brain and CNS. Also expressed in the small intestine and testis, but not in normal lymphoid cells.
    • Involvement in diseaseA chromosomal aberration involving ALK is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with NPM1. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated. The constitutively active fusion proteins are responsible for 5-10% of non-Hodgkin lymphomas.
      A chromosomal aberration involving ALK is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with CARS; translocation t(2;4)(p23;q21) with SEC31A.
      A chromosomal aberration involving ALK is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALO17.
      Neuroblastoma 3
      The ALK signaling pathway plays an important role in glioblastoma, the most common malignant brain tumor of adults and one of the most lethal cancers. It regulates both glioblastoma migration and growth.
      A chromosomal aberration involving ALK is found in one subject with colorectal cancer. Translocation t(2;2)(p23.1;p23.3). A 5 million base pair tandem duplication generates an in-frame WDCP-ALK gene fusion.
    • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.
      Contains 1 LDL-receptor class A domain.
      Contains 2 MAM domains.
      Contains 1 protein kinase domain.
    • Post-translational
      Phosphorylated at tyrosine residues by autocatalysis, which activates kinase activity. In cells not stimulated by a ligand, receptor protein tyrosine phosphatase beta and zeta complex (PTPRB/PTPRZ1) dephosphorylates ALK at the sites in ALK that are undergoing autophosphorylation through autoactivation. Phosphorylation at Tyr-1507 is critical for SHC1 association.
    • Cellular localizationCell membrane. Membrane attachment was crucial for promotion of neuron-like differentiation and cell proliferation arrest through specific activation of the MAP kinase pathway.
    • Information by UniProt
    • Database links
    • Alternative names
      • Alk antibody
      • ALK tyrosine kinase receptor antibody
      • ALK/EML4 fusion gene, included antibody
      • ALK/NPM1 fusion gene, included antibody
      • ALK_HUMAN antibody
      • anaplastic lymphoma kinase (Ki-1) antibody
      • Anaplastic lymphoma kinase antibody
      • Anaplastic lymphoma kinase Ki1 antibody
      • anaplastic lymphoma receptor tyrosine kinase antibody
      • CD 246 antibody
      • CD246 antibody
      • CD246 antigen antibody
      • EC antibody
      • Ki 1 antibody
      • Ki1 antibody
      • mutant anaplastic lymphoma kinase antibody
      • NBLST 3 antibody
      • NBLST3 antibody
      • Tcrz antibody
      • TFG/ALK antibody
      see all

    Anti-ALK antibody [SP8], prediluted images

    • Staining of human anaplastic lymphoma using ab27599

    References for Anti-ALK antibody [SP8], prediluted (ab27599)

    ab27599 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab27599.
    Please use the links above to contact us or submit feedback about this product.